- Home
- UVV vs OPK Comparison
UVV vs OPK Comparison
Compare UVV & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVV
- OPK
- Stock Information
- Founded
- UVV 1886
- OPK 2007
- Country
- UVV United States
- OPK United States
- Employees
- UVV N/A
- OPK N/A
- Industry
- UVV Farming/Seeds/Milling
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- UVV Industrials
- OPK Health Care
- Exchange
- UVV Nasdaq
- OPK Nasdaq
- Market Cap
- UVV 1.3B
- OPK 1.3B
- IPO Year
- UVV N/A
- OPK 1995
- Fundamental
- Price
- UVV $56.00
- OPK $1.66
- Analyst Decision
- UVV
- OPK Strong Buy
- Analyst Count
- UVV 0
- OPK 3
- Target Price
- UVV N/A
- OPK $2.75
- AVG Volume (30 Days)
- UVV 150.2K
- OPK 4.1M
- Earning Date
- UVV 05-21-2025
- OPK 05-06-2025
- Dividend Yield
- UVV 5.79%
- OPK N/A
- EPS Growth
- UVV 5.05
- OPK N/A
- EPS
- UVV 4.86
- OPK N/A
- Revenue
- UVV $2,827,901,000.00
- OPK $713,142,000.00
- Revenue This Year
- UVV N/A
- OPK N/A
- Revenue Next Year
- UVV N/A
- OPK $6.25
- P/E Ratio
- UVV $11.54
- OPK N/A
- Revenue Growth
- UVV 6.40
- OPK N/A
- 52 Week Low
- UVV $45.19
- OPK $1.15
- 52 Week High
- UVV $59.13
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- UVV 59.76
- OPK 40.64
- Support Level
- UVV $53.55
- OPK $1.75
- Resistance Level
- UVV $56.89
- OPK $1.80
- Average True Range (ATR)
- UVV 1.17
- OPK 0.06
- MACD
- UVV 0.09
- OPK -0.03
- Stochastic Oscillator
- UVV 69.41
- OPK 8.70
About UVV Universal Corporation
Universal Corp is a global leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segment includes Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.